Steven L. Tuch - 27 Feb 2024 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Reporting relationship: Chief Financial Officer
Issuer ticker: VTVT
Reported as of: 27 Feb 2024
Net transaction value: +$734,098
SEC form: 4
Accepted by SEC: 13 Jun 2024, 16:38:28 UTC
Prior SEC filing: 13 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Paul J. Sekhri as Attorney-in-Fact

Key filing fact

Steven L. Tuch filed Form 4 for vTv Therapeutics Inc. (VTVT) on 13 Jun 2024.

Key facts

This page summarizes Steven L. Tuch's Form 4 filing for vTv Therapeutics Inc. (VTVT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Jun 2024, 16:38.

Change

Previous filing in this sequence was filed on 13 Dec 2022.
Current net transaction value: +$734,098.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTVT transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $734,098
Shares: +62,159
Change %: +497%
Price: $11.81
Shares after: 74,659
Date: 27 Feb 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 62,159
Exercise price: $11.81
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in quarterly equal installments over the three year period beginning on February 27, 2024. The option was conditioned upon shareholder approval of the 2024 Equity Incentive Plan, which was approved by the shareholders on June 11, 2024.